- Kingscrowd Newsletter
- Posts
- How LLCs vs. C-Corps Affect Your Investment Taxes — and What the Reg CF Data Shows
How LLCs vs. C-Corps Affect Your Investment Taxes — and What the Reg CF Data Shows
Learn how LLC vs. C-Corp structures can affect your taxes—including K-1s and QSBS—and what the Reg CF data reveals about how startups are structured by industry.
WEBINAR TOMORROW: ASSET-BASED SECURITIES
Last Chance to Register: Kingscrowd x Percent Webinar is Tomorrow!
We’re sitting down with Prath Reddy, CFA, President of Percent, to discuss how asset-based securities (ABS) are redefining the fixed-income landscape in 2025.
💡 What You’ll Learn:
• The rise of ABS and its market momentum
• How ABS compares to bonds and alternatives
• Strategies to assess risk and strengthen your portfolio
📅 Date: Wednesday, April 2
⏰ Time: 12 PM ET / 9 AM PT
🎟️ Free to attend
CHART OF THE WEEK 📈
By Brian Belley | Read
Did you know the type of company you invest in can significantly impact your taxes — and potentially your after-tax returns? With Tax Day fast approaching, it's a good time to consider how a startup’s legal structure may influence your portfolio.
We've analyzed Regulation Crowdfunding data going back to 2016 and found notable differences in how companies structure themselves across industries. For example, businesses in sectors like Food & Beverage, Real Estate, and Retail tend to favor LLC structures, which can mean more complicated tax filings for investors (think K-1 forms - though these tend to be more uncommon in recent years). In contrast, high-growth industries such as Fintech, Software/SaaS, Cybersecurity, Healthcare/Pharma, Energy, and Transportation & Aviation overwhelmingly choose C-Corporations — making these companies potentially eligible for lucrative QSBS tax benefits.

Curious about how these structures might affect your tax strategy — and interested in digging deeper into LLC vs. C-Corp considerations? Check out our latest article, featuring insights, practical tips, and an additional data-driven chart showing the overall breakdown of offering entity types in Reg CF since 2016.
(Note: This information is educational only and should not be considered professional tax advice. Always consult a qualified tax professional for guidance specific to your situation.)
Want to share some thoughts on this story or have suggestions for a future chart? Reply to this email!
READY FOR TAX SEASON?
Have questions about how to handle your startup investments while filing taxes? Check out Kingscrowd’s Tax Center to get a quick look at your startup portfolio’s exits and failures.
INVEST IN KINGSCROWD
Kingscrowd is on a mission to empower everyday investors with data-driven insights into the private markets—and now, you have the chance to invest in us!
Our raise has 1 month left on StartEngine, and we’d love for you to check out the details of our offering.
🔎 Why Kingscrowd?
✅ The first comprehensive ratings & analytics platform for startup investing
✅ A proven track record of helping investors navigate the private markets
✅ Positioned for growth as the equity crowdfunding industry and retail investing expands
Becoming a shareholder means joining us in shaping the future of startup investing.
STAFF PICKS 🌶️
By Teddy Lyons
Never thought that graphene would get me so excited, but here we are. Avadain is one of my favorite equity crowdfunded companies. I invested in 2023, and now Avadain is raising at a nearly ~2X markup from that round and has officially signed its first licensing agreement for its large, thin, defect-free graphene flakes. Is the valuation increase justified?
By Léa Bouhelier-Gautreau
Sirocco Energy impressed me 2 years ago when it launched on Wefunder with $80 million in pre-orders. Today, the company is raising to launch production of its small-scale wind turbines. But it isn't mentioning its pre-orders anymore and has a short runway. Is the opportunity still exciting?
By Teddy Lyons
I’m always cautious when it comes to lending companies, but Doc2Doc is on to something here. Essentially, they have pioneered a new underwriting model for doctors, who have unique risk profiles not captured by traditional risk assessment scores like FICO. While the company has dispersed $136M+ in loans and secured additional $100M in lending capacity, my diligence before investing is around the mechanics of the new underwriting model and cohort analysis of each block of new loans. Are defaults higher than traditional finance options?
What did you think of this newsletter? |
Enjoyed this newsletter? Forward it to an investing-minded friend and have them signup here.